SCHEMBL7183096

SCHEMBL7183096

COc1cccc(OC)c1C(=O)[PH](=O)CCCCCCCCc1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.51
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
PPARA Q07869 1/20 0.47
PLK1 P53350 1/20 0.46
HPGD P15428 1/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
CA14 Q9ULX7 1/20 0.44
ALOX5 P09917 1/20 0.43
FAAH O00519 1/20 0.42
MAPT P10636 1/20 0.42
RXFP1 Q9HBX9 1/20 0.42
ACHE P22303 1/20 0.42
SGMS1 Q86VZ5 1/20 0.42
SGMS2 Q8NHU3 1/20 0.42
ALDH1A1 P00352 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL444639 1.00 TAAR1 (0.51) TAAR1MEN1KMT2APPARAPLK1
SCHEMBL29077322 1.00 TAAR1 (0.51) TAAR1MEN1KMT2APPARAPLK1
SCHEMBL7177010 1.00 TAAR1 (0.51) TAAR1MEN1KMT2APPARAPLK1
SCHEMBL448034 1.00 TAAR1 (0.51) TAAR1MEN1KMT2APPARAPLK1
SCHEMBL7175739 1.00 TAAR1 (0.51) TAAR1MEN1KMT2APPARAPLK1
SCHEMBL7188549 1.00 TAAR1 (0.51) TAAR1MEN1KMT2APPARAPLK1
SCHEMBL7185434 0.99 TAAR1 (0.52) TAAR1MEN1KMT2APPARAPLK1
SCHEMBL7174914 0.95 TAAR1 (0.53) TAAR1MEN1KMT2APPARAPLK1
SCHEMBL7188946 0.92 TAAR1 (0.46) TAAR1MEN1KMT2APPARAPLK1
SCHEMBL7189232 0.92 TAAR1 (0.46) TAAR1MEN1KMT2APPARAPLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6579663-B2 Chemical intermediates such as lithium 2,6-dimethylbenzoyl phenylphosphine for preparation of acylphosphines, acylphosphine oxides or acylphosphine sulfides CIBA SPECIALTY CHEMICALS CORPORATION 2003-06-17 US disclosed
US-20020107413-A1 Organometallic monoacylarylphosphines WOLF JEAN-PIERRE (CH) 2002-08-08 US disclosed
US-6399805-B2 SUCH AS LITHIUM 2,6-DIMETHYLBENZOYLPHENYLPHOSPHINE, USE AS PHOTOINITIATORS IN PHOTOCURABLE COMPOSITIONS SUCH AS FOR PHOTOGRAPHIC PRODUCTION OF RELIEF IMAGES CIBA SPECIALTY CHEMICALS CORPORATION 2002-06-04 US disclosed
US-20010031898-A1 Organometallic monoacylarylphosphines CIBA SPECIALTY CHEMICALS CORP. 2001-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020107413-A1 Organometallic monoacylarylphosphines CBR1, NAF1, DHCR24 TAAR1 1345/4885MEN1 2312/4885KMT2A 1586/4885
US-20010031898-A1 Organometallic monoacylarylphosphines NAF1, DHCR24, CBR1 TAAR1 1464/4885MEN1 2263/4885KMT2A 956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.